Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-25 @ 4:58 AM
NCT ID:
NCT06263218
Eligibility Criteria:
Inclusion Criteria:
* Received a single kidney transplant after January 1, 2018
* Age over 18 years at time of kidney transplant.
* It was under preemptive strategy.
* Diagnosed with CMV infection/disease within the first 12 months after kidney transplant.
* Follow-up information is available in medical records for at least 12 months after confirmation of CMV infection, or even loss of the allograft, death of the recipient or loss of follow-up of the receiver, when/if applicable.
Exclusion Criteria:
* Diagnosed as a carrier of the human immunodeficiency virus (HIV+), hepatitis B virus and/or hepatitis C before kidney transplantation.
* Participation in any interventional study during the period between kidney transplantation and a period of 12 months after CMV diagnosis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06263218
Study Brief:
Protocol Section:
NCT06263218